Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent Oxytocin for Labor Induction
NCT04017247Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Nov 2019
- Primary completion
- Jun 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of oxytocin in induction of labor (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Delivery within 24 hours. Started Nov 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
induction of labor
Beyond the preview
Go deeper on NCT04017247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04017247.